Mesoporous silica nanoparticles for cancer theranostic drug delivery

Yaoxue Xuebao

Volumn 48, Issue 1, 2013, Pages 8-13

  Wang, Xin ^a   Teng, Zhao Gang ^a   Huang, Xiao Yin ^a   Lu, Guang Ming ^a  

^a JINLING HOSPITAL   (China)

Author keywords

Carcinoma; Drug carrier; Nanoparticle; Silicon dioxide

Indexed keywords

ANTINEOPLASTIC AGENT; NANOPARTICLE; SILICON DIOXIDE;

CANCER CHEMOTHERAPY; CANCER RESISTANCE; DRUG DELIVERY SYSTEM; DRUG TARGETING; POROSITY; REVIEW;

ANIMALS; ANTINEOPLASTIC AGENTS; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; NANOPARTICLES; NEOPLASMS; POROSITY; SILICON DIOXIDE;

EID: 84875039697     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Chidambaram M, Manavalan R, Kathiresan K. Nanotherapeutics to overcome conventional cancer chemotherapy limitations [J]. J Pharm Pharm Sci, 2011, 14: 67-77.
2. Vallet-Regi M, Balas F, Arcos D. Mesoporous materials for drug delivery [J]. Angew Chem Int Ed Engl, 2007, 46: 7548-7558. (Pubitemid 47556998)
3. Chu Z, Huang Y, Tao Q, et al. Cellular uptake, evolution, and excretion of silica nanoparticles in human cells [J]. Nanoscale, 2011, 3: 3291-3299.
4. Trewyn BG, Giri S, Slowing II, et al. Mesoporous silica nanoparticle based controlled release, drug delivery, and biosensor systems [J]. Chem Commun, 2007, 43: 3236-3245. (Pubitemid 47197838)
5. Tang F, Li L, Chen D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery [J]. Adv Mater, 2012, 24: 1504-1534.
6. Slowing II, Trewyn BG, Giri S, et al. Mesoporous silica nanoparticles for drug delivery and biosensing applications [J]. Adv Funct Mater, 2007, 17: 1225-1236. (Pubitemid 46847636)
7. He QJ, Zhang ZW, Gao Y, et al. Intracellular localization and cytotoxicity of spherical mesoporous silica nano- and microparticles [J]. Small, 2009, 5: 2722-2729.
8. Lu J, Liong M, Li Z, et al. Biocompatibility, biodistribution, and drug-delivery efficiency of mesoporous silica nanoparticles for cancer therapy in animals [J]. Small, 2010, 6: 1794-1805.
9. Hon NK, Shaposhnik Z, Diebold ED, et al. Tailoring the biodegradability of porous silicon nanoparticles [J]. J Biomed Mater Res A, 2012, 100: 3416-3421.
10. Ohno K, Akashi T, Tsujii Y, et al. Blood clearance and biodistribution of polymer brush-afforded silica particles prepared by surface-initiated living radical polymerization [J]. Biomacromolecules, 2012, 13: 927-936.
11. Slowing II, Vivero-Escoto JL, Wu CW, et al. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers [J]. Adv Drug Deliv Rev, 2008, 60: 1278-1288.
12. Wang SB. Ordered mesoporous materials for drug delivery [J]. Micro Meso Mater, 2009, 117: 1-9.
13. Tsai CH, Vivero-Escoto JL, Slowing II, et al. Surfactant-assisted controlled release of hydrophobic drugs using anionic surfactant templated mesoporous silica nanoparticles [J]. Biomaterials, 2011, 32: 6234-6244.
14. Hom C, Lu J, Liong M, et al. Mesoporous silica nanoparticles facilitate delivery of siRNA to shutdown signaling pathways in mammalian cells [J]. Small, 2010, 6: 1185-1190.
15. Chung TH, Wu SH, Yao M, et al. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells [J]. Biomaterials, 2007, 28: 2959-2966. (Pubitemid 46560868)
16. Trewyn BG, Nieweg JA, Zhao YN, et al. Biocompatible mesoporous silica nanoparticles with different morphologies for animal cell membrane penetration [J]. Chem Eng J, 2008, 137:23-29.
17. Li L, Guan Y, Liu H, et al. Silica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy [J]. ACS Nano, 2011, 5: 7462-7470.
18. Lin J, Chu P, Wei Z. A new dual immunoassay for tumor markers based on chemilluminescence signal amplification by magnetic mesoporous silica and enzyme modified gold nanoparticles [J]. Anal Sci, 2012, 28: 21-25.
19. Qian J, Dai H, Pan X, et al. Simultaneous detection of dual proteins using quantum dots coated silica nanoparticles as labels [J]. Biosens Bioelectron, 2011, 28: 314-319.
20. Mi Y, Li K, Liu Y, et al. Herceptin functionalized polyhedral oligomeric silsesquioxane - conjugated oligomers - silica/iron oxide nanoparticles for tumor cell sorting and detection [J]. Biomaterials, 2011, 32: 8226-8233.
21. 2 nanoparticles for use as an efficient MRI contrast agent [J]. Contrast Media Mol Imaging, 2011, 6: 110-118.
22. Zhan Q, Qian J, Li X, et al. A study of mesoporous silica-encapsulated gold nanorods as enhanced light scattering probes for cancer cell imaging [J]. Nanotechnology, 2010, 21: 055704.
23. Jennings LE, Long NJ. 'Two is better than one' - probes for dual-modality molecular imaging [J]. Chem Commun (Camb), 2009, 18: 3511-3524.
24. Luo T, Huang P, Gao G, et al. Mesoporous silica-coated gold nanorods with embedded indocyanine green for dual mode X-ray CT and NIR fluorescence imaging [J]. Optics Express, 2011, 19: 17030-17039.
25. Huang X, Zhang F, Lee S, et al. Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes [J]. Biomaterials, 2012, 33: 4370-4378.
26. Benezra M, Penate-Medina O, Zanzonico PB, et al. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma [J]. J Clin Invest, 2011, 121: 2768-2780.
27. Li L, Tang F, Liu H, et al. In vivo delivery of silica nanorattle encapsulated docetaxel for liver cancer therapy with low toxicity and high efficacy [J]. ACS Nano, 2010, 4: 6874-6882.
28. Stubbs M, McSheehy PMJ, Griffiths JR, et al. Causes and consequences of tumor acidity and implications for treatment [J]. Mol Med Today, 2000, 6: 15-19. (Pubitemid 30010232)
29. Zheng H, Wang Y, Che S. Coordination bonding-based mesoporous silica for pH-responsive anticancer drug doxorubicin delivery [J]. J Phys Chem C, 2011, 115: 16803-16813.
30. Singh N, Karambelkar A, Gu L, et al. Bioresponsive mesoporous silica nanoparticles for triggered drug release [J]. J Am Chem Soc, 2011, 133: 19582-19585.
31. Zhao Y, Vivero-Escoto JL, Slowing II, et al. Capped mesoporous silica nanoparticles as stimuli-responsive controlled release systems for intracellular drug/gene delivery [J]. Expert Opin Drug Deliv, 2010, 7: 1013-1029.
32. Rim HP, Min KH, Lee HJ, et al. pH-Tunable calcium phosphate covered mesoporous silica nanocontainers for intracellular controlled release of guest drugs [J]. Angew Chem Int Ed Engl, 2011, 50: 8853-8857.
33. Muhammad F, Guo M, Qi W, et al. pH-Triggered controlled drug release from mesoporous silica nanoparticles via intracelluar dissolution of ZnO nanolids [J]. J Am Chem Soc, 2011, 133: 8778-8781.
34. Ding RM, He H, Li J. Research progress of polyamidoamine dendrimer in targeting drug delivery system [J]. Acta Pharm Sin, 2011, 46: 493-501.
35. Roy I, Ohulchanskyy TY, Pudavar HE, et al. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: a novel drug-carrier system for photodynamic therapy [J]. J Am Chem Soc, 2003, 125: 7860-7865. (Pubitemid 36782161)
36. Roy I, Ohulchanskyy TY, Bharali DJ, et al. Optical tracking of organically modified silica nanoparticles as DNA carriers: a nonviral, nanomedicine approach for gene delivery [J]. Proc Natl Acad Sci USA, 2005, 102: 279-284. (Pubitemid 40116758)
37. Rhyner MN, Smith AM, Gao X, et al. Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging [J]. Nanomed, 2006, 1: 209-217.
38. Thierry B. Drug nanocarriers and functional nanoparticles: applications in cancer therapy [J]. Curr Drug Deliv, 2009, 6: 391-403.
39. Slowing I, Trewyn BG, Lin VS. Effect of surface functionalization of MCM-41-type mesoporous silica nanoparticles on the endocytosis by human cancer cells [J]. J Am Chem Soc, 2006, 128: 14792-14793. (Pubitemid 44851603)
40. Rosenholm JM, Meinander A, Peuhu E, et al. Targeting of porous hybrid silica nanoparticles to cancer cells [J]. ACS Nano, 2009, 3: 197-206.
41. Fan J, Fang G, Wang X, et al. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles [J]. Nanotechnology, 2011, 22: 455102.
42. Pan L, He Q, Liu J, et al. Nuclear-targeted drug delivery of TAT peptide-conjugated monodisperse mesoporous silica nanoparticles [J]. J Am Chem Soc, 2012, 134: 5722-5725.
43. Ferris DP, Lu J, Gothard C, et al. Synthesis of biomolecule-modified mesoporous silica nanoparticles for targeted hydrophobic drug delivery to cancer cells [J]. Small, 2011, 7: 1816-1826.
44. Gao Y, Chen Y, Ji X, et al. Controlled intracellular release of doxorubicin in multidrug-resistant cancer cells by tuning the shell-pore sizes of mesoporous silica nanoparticles [J]. ACS Nano, 2011, 5: 9788-9798.
45. Huang IP, Sun SP, Cheng SH, et al. Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein- mediated drug resistance [J]. Mol Cancer Ther, 2011, 10: 761-769.
46. He Q, Gao Y, Zhang L, et al. A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance [J]. Biomaterials, 2011, 32: 7711-7720.
47. Chen AM, Zhang M, Wei D, et al. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells [J]. Small, 2009, 5: 2673-2677.
48. Meng H, Liong M, Xia T, et al. Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line [J]. ACS Nano, 2010, 4: 4539-4550.
49. Rosenholm JM, Sahlgren C, Linden M. Multifunctional mesoporous silica nanoparticles for combined therapeutic, diagnostic and targeted action in cancer treatment [J]. Curr Drug Targets, 2011, 12: 1166-1186.
50. Singh AK, Hahn MA, Gutwein LG, et al. Multi-dye theranostic nanoparticle platform for bioimaging and cancer therapy [J]. Int J Nanomedicine, 2012, 7: 2739-2750.
51. Huang CC, Huang W, Yeh CS. Shell-by-shell synthesis of multi-shelled mesoporous silica nanospheres for optical imaging and drug delivery [J]. Biomaterials, 2011, 32: 556-564.
52. Liu Q, Zhang J, Sun W, et al. Delivering hydrophilic and hydrophobic chemotherapeutics simultaneously by magnetic mesoporous silica nanoparticles to inhibit cancer cells [J]. Int J Nanomedicine, 2012, 7: 999-1013.
53. Lee CH, Cheng SH, Huang IP, et al. Intracellular pH-responsive mesoporous silica nanoparticles for the controlled release of anticancer chemotherapeutics [J]. Angew Chem Int Ed Engl, 2010, 49: 8214-8219.
54. Ma M, Chen H, Chen Y, et al. Au capped magnetic core/mesoporous silica shell nanoparticles for combined photothermo-/chemo-therapy and multimodal imaging [J]. Biomaterials, 2012, 33: 989-998.
55. Ashley CE, Carnes EC, Phillips GK, et al. The targeted delivery of multicomponent cargos to cancer cells by nanoporous particle-supported lipid bilayers [J]. Nat Mater, 2011, 10: 389-397.